Once-Daily Oral Levofloxacin Monotherapy versus Piperacillin/Tazobactam Three Times a Day: A Randomized Controlled Multicenter Trial in Patients with Febrile Neutropenia-Reference-Cited by-同舟云学术

Once-Daily Oral Levofloxacin Monotherapy versus Piperacillin/Tazobactam Three Times a Day: A Randomized Controlled Multicenter Trial in Patients with Febrile Neutropenia

Published:2004-01 Issue:1 Volume:79 Page:74-78
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Cornely Oliver A.,Wicke Thomas,Seifert Harald,Bethe Ullrich,Schwonzen Martin,Reichert Dietmar,Ullmann Andrew J.,Karthaus Meinolf,Breuer Kai,Salzberger Bernd,Diehl Volker,Fätkenheuer Gerd

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/article/10.1007/BF02983537/fulltext.html

Reference28 articles.

1. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.Clin Infect Dis. 2002;34:730–751.

2. Link H, Böhme A, Cornely OA, et al. Antimicrobial therapy of unexplained fever in neutropenic patients.Ann Hematol. 2003;82(suppl 2):105–117.

3. Kern WV. Risk assessment and risk-based therapeutic strategies in febrile neutropenia.Curr Opin Infect Dis. 2001;14:415–422.

4. Cornely OA, Bethe U, Salzberger B, et al. Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever.Ann Hematol. 2001;80:103–108.

5. Cornely OA, Bethe U, Seifert H, et al. A randomized monocentric trial in febrile neutropenic patients: ceftriaxone and gentamicin vs cefepime and gentamicin.Ann Hematol. 2002;81:37–43.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Sites of Infections and Types of Microorganisms in Patient with Febrile Neutropenia in Hematological Wards – Single Center Study;Open Access Macedonian Journal of Medical Sciences;2022-03-07

2. Efficacy and Safety of Sitafloxacin in Treating Low-risk Febrile Neutropenia in Patients with Lung Cancer;JMA Journal;2022

3. Efficacy of oral levofloxacin monotherapy against low-risk FN in patients with malignant lymphoma who received chemotherapy using the CHOP regimen;Journal of Clinical and Experimental Hematopathology;2020

4. Infection in the Patient With Cancer;Abeloff's Clinical Oncology;2020

5. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?;Supportive Care in Cancer;2019-10-31